214 related articles for article (PubMed ID: 36719617)
1. Altered gut microbiota in patients with idiopathic Parkinson's disease: an age-sex matched case-control study.
Babacan Yildiz G; Kayacan ZC; Karacan I; Sumbul B; Elibol B; Gelisin O; Akgul O
Acta Neurol Belg; 2023 Jun; 123(3):999-1009. PubMed ID: 36719617
[TBL] [Abstract][Full Text] [Related]
2. Altered gut microbiota in Parkinson's disease patients with motor complications.
Takahashi K; Nishiwaki H; Ito M; Iwaoka K; Takahashi K; Suzuki Y; Taguchi K; Yamahara K; Tsuboi Y; Kashihara K; Hirayama M; Ohno K; Maeda T
Parkinsonism Relat Disord; 2022 Feb; 95():11-17. PubMed ID: 34954497
[TBL] [Abstract][Full Text] [Related]
3. Altered gut microbiota in Parkinson's disease patients/healthy spouses and its association with clinical features.
Zhang F; Yue L; Fang X; Wang G; Li C; Sun X; Jia X; Yang J; Song J; Zhang Y; Guo C; Ma G; Sang M; Chen F; Wang P
Parkinsonism Relat Disord; 2020 Dec; 81():84-88. PubMed ID: 33099131
[TBL] [Abstract][Full Text] [Related]
4. Gut Microbiota and Its Repercussion in Parkinson's Disease: A Systematic Review in Occidental Patients.
Proano AC; Viteri JA; Orozco EN; Calle MA; Costa SC; Reyes DV; German-Montenegro M; Moncayo DF; Tobar AC; Moncayo JA
Neurol Int; 2023 Jun; 15(2):750-763. PubMed ID: 37368331
[TBL] [Abstract][Full Text] [Related]
5. Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome.
Hill-Burns EM; Debelius JW; Morton JT; Wissemann WT; Lewis MR; Wallen ZD; Peddada SD; Factor SA; Molho E; Zabetian CP; Knight R; Payami H
Mov Disord; 2017 May; 32(5):739-749. PubMed ID: 28195358
[TBL] [Abstract][Full Text] [Related]
6. The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder.
Heintz-Buschart A; Pandey U; Wicke T; Sixel-Döring F; Janzen A; Sittig-Wiegand E; Trenkwalder C; Oertel WH; Mollenhauer B; Wilmes P
Mov Disord; 2018 Jan; 33(1):88-98. PubMed ID: 28843021
[TBL] [Abstract][Full Text] [Related]
7. Parkinson's Disease and the Gut Microbiome in Rural California.
Zhang K; Paul KC; Jacobs JP; Chou HL; Duarte Folle A; Del Rosario I; Yu Y; Bronstein JM; Keener AM; Ritz B
J Parkinsons Dis; 2022; 12(8):2441-2452. PubMed ID: 36442206
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota in patients with Parkinson's disease in southern China.
Lin A; Zheng W; He Y; Tang W; Wei X; He R; Huang W; Su Y; Huang Y; Zhou H; Xie H
Parkinsonism Relat Disord; 2018 Aug; 53():82-88. PubMed ID: 29776865
[TBL] [Abstract][Full Text] [Related]
9. [Features of gut microbiota in patients with idiopathic Parkinson's disease].
Li Y; Li RX; Du YT; Xu XJ; Xue Y; Gao D; Gao T; Sheng Z; Zhang LY; Tuo HZ
Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(13):1017-1022. PubMed ID: 32294860
[No Abstract] [Full Text] [Related]
10. Study of the gut microbiome in Egyptian patients with Parkinson's Disease.
Mehanna M; AbuRaya S; Ahmed SM; Ashmawy G; Ibrahim A; AbdelKhaliq E
BMC Microbiol; 2023 Jul; 23(1):196. PubMed ID: 37481569
[TBL] [Abstract][Full Text] [Related]
11. Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson's disease.
Cui C; Han Y; Li H; Yu H; Zhang B; Li G
Front Cell Infect Microbiol; 2022; 12():887407. PubMed ID: 36034698
[TBL] [Abstract][Full Text] [Related]
12. Microbiota-mediated effects of Parkinson's disease medications on Parkinsonian non-motor symptoms in male transgenic mice.
Radisavljevic N; Metcalfe-Roach A; Cirstea M; Tabusi MM; Bozorgmehr T; Bar-Yoseph H; Finlay BB
mSphere; 2024 Jan; 9(1):e0037923. PubMed ID: 38078745
[TBL] [Abstract][Full Text] [Related]
13. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease.
Lin CH; Chen CC; Chiang HL; Liou JM; Chang CM; Lu TP; Chuang EY; Tai YC; Cheng C; Lin HY; Wu MS
J Neuroinflammation; 2019 Jun; 16(1):129. PubMed ID: 31248424
[TBL] [Abstract][Full Text] [Related]
14. Alteration of the fecal microbiota in Chinese patients with Parkinson's disease.
Qian Y; Yang X; Xu S; Wu C; Song Y; Qin N; Chen SD; Xiao Q
Brain Behav Immun; 2018 May; 70():194-202. PubMed ID: 29501802
[TBL] [Abstract][Full Text] [Related]
15. Alterations of gut microbiota and metabolome with Parkinson's disease.
Yan Z; Yang F; Cao J; Ding W; Yan S; Shi W; Wen S; Yao L
Microb Pathog; 2021 Nov; 160():105187. PubMed ID: 34530073
[TBL] [Abstract][Full Text] [Related]
16. Study of gut microbiota alterations in Alzheimer's dementia patients from Kazakhstan.
Kaiyrlykyzy A; Kozhakhmetov S; Babenko D; Zholdasbekova G; Alzhanova D; Olzhayev F; Baibulatova A; Kushugulova AR; Askarova S
Sci Rep; 2022 Sep; 12(1):15115. PubMed ID: 36068280
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiota in Parkinson's disease: Temporal stability and relations to disease progression.
Aho VTE; Pereira PAB; Voutilainen S; Paulin L; Pekkonen E; Auvinen P; Scheperjans F
EBioMedicine; 2019 Jun; 44():691-707. PubMed ID: 31221587
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.
Sun MF; Zhu YL; Zhou ZL; Jia XB; Xu YD; Yang Q; Cui C; Shen YQ
Brain Behav Immun; 2018 May; 70():48-60. PubMed ID: 29471030
[TBL] [Abstract][Full Text] [Related]
19. Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls.
Unger MM; Spiegel J; Dillmann KU; Grundmann D; Philippeit H; Bürmann J; Faßbender K; Schwiertz A; Schäfer KH
Parkinsonism Relat Disord; 2016 Nov; 32():66-72. PubMed ID: 27591074
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of gut microbiota and its response to a Chinese Herbal Formula in elder patients with metabolic syndrome.
Ni Y; Mu C; He X; Zheng K; Guo H; Zhu W
Drug Discov Ther; 2018; 12(3):161-169. PubMed ID: 29998997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]